$Biorestorative Therapies (BRTX.US)$ NEWS BioRestorative The...
NEWS
BioRestorative Therapies Announces FDA Clearance of Phase 2 BRTX-100 Clinical Study Protocol Amendment
BioRestorative Therapies announces FDA clearance of Phase 2 BRTX-100 clinical study protocol amendment, replacing saline injections with sham injections in the control group. The amendment aims to enhance safety and prevent transient clinical outcomes, maintaining the 2024 enrollment completion target.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment